Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
BlackRock, Inc. reported a 15.00% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 15.00% stake in Arrowhead Pharmaceuticals, Inc., 20,323,221 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 15.00%
- Shares
- 20,323,221
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 15.00% | 20,323,221 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- BlackRock, Inc.
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 23, 2025
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Cohen Matthew Gregory · Jun 17, 2026